Premium Insights - Digital Health

Read our Analysts’ insights and expert opinions on the latest healthcare technology industry developments and market trends. Signify Research provides both free insights and premium insights which are only available to subscribers of "Signify Premium Insights".
Click on the premium insights link below to filter for just the premium content.



SPI Digital Health: b.well, Samsung and the Consumerisation of Health

Signify Premium Insights – Digital Health Subscription Required

8th November 2023 – A personalised health data platform being developed by b.well for Samsung smartphone users relies on changing data sharing regulations. While b.well enjoys first mover advantage, it is not alone in its ambitions.

SPI Digital Health: Gen AI’s Juggernaut and the Low Hanging Fruit

Signify Premium Insights – Digital Health Subscription Required

2nd November 2023 – In the fluid, fast-moving generative AI space, a couple of application areas in the care network offer significant opportunity for vendors. But as competition intensifies, vendors must set their sights higher in the value chain.

SPI Digital Health: Dedalus Dead Set on Expansion

Signify Premium Insights – Digital Health Subscription Required

31st October 2023 – By taking another 19% share in Dedalus, private investment house Ardian plans to drive the Italian EHR vendor’s next expansion phase. In doing so, Ardian will need to account for some product portfolio challenges facing Dedalus.

SPI Digital Health: InterSystems Ramps up Support for Startups

Signify Premium Insights – Digital Health Subscription Required

27th October 2023 – As InterSystems strengthens its support for health tech startups, can it continue to make headway in global markets in the face of tough competition from tier-1 vendors?

SPI Digital Health: Wolters Kluwer Takes Next Logical Step with UptoDate

Signify Premium Insights – Digital Health Subscription Required

25th October 2023 – Wolters Kluwer Health’s decision to bring generative AI into its UpToDate clinical decision support solution is logical. But further down the line gen AI’s greater upside potential may lie in another of the Dutch vendor’s solutions.